Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden

  title={Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden},
  author={Marios Rossides and Susanna Kullberg and Johan Grunewald and Anders Eklund and Daniela Di Giuseppe and Johan Askling and Elizabeth V. Arkema},
Objectives Previous studies showed a strong association between sarcoidosis and heart failure (HF) but did not consider risk stratification or risk factors to identify useful aetiological insights. We estimated overall and stratified HRs and identified risk factors for HF in sarcoidosis. Methods Sarcoidosis cases were identified from the Swedish National Patient Register (NPR; ≥2 International Classification of Diseases-coded visits, 2003–2013) and matched to general population comparators… Expand


The long-term prognostic significance of heart failure in sarcoidosis patients ─ a cohort study
Sarcoidosis is independentlyassociated with HF, and both are independently associated with all-cause mortality. Expand
Sarcoidosis mortality in Sweden: a population-based cohort study
Investigating sarcoidosis mortality in a large, population-based cohort found patients whose disease leads to treatment around diagnosis have a two-fold increased risk of death, and future interventions should focus on this vulnerable group. Expand
Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study
Sarcoidosis cases treated with immunosuppressants around diagnosis had a three-fold increased risk, whereas nontreated patients had a 50% increased risk and the rate of serious infection recurrence was 2.8-fold higher in cases than in comparators. Expand
Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013
Significantly increased risk was also observed for several types of CVD, including coronary artery disease, congestive heart failure, atrial fibrillation and cerebrovascular accident, in this population-based cohort. Expand
Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids
Sarcoidosis is associated with an increased risk of type 2 diabetes mellitus especially in older, male, corticosteroid-treated patients at diagnosis, and this risk is higher for male and older patients compared with female and younger patients. Expand
Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
Patients with sarcoidosis had a higher associated risk of HF and other adverse cardiac outcomes compared with matched control subjects. Expand
Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
In this cohort study, RA was associated with an increased hospitalization for HF, and this findings add significantly to the existing evidence of RA as a clinically relevant risk factor for HF. Expand
Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden
The annual incidence rate of HF declined over time, while prevalence of HF has increased, suggesting that patients with HF were surviving longer over time. Expand
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
Investigation HF among patients with AF was independently associated with higher risk of mortality, all-cause hospitalization, and bleeding events, and traditional HF risk factors, AF type, and baseline heart rate are independent clinical predictors of incident HF. Expand
Increased risk of ventricular tachycardia in patients with sarcoidosis during the very long term follow-up.
Sarcoidosis may increase the predisposition to ventricular arrhythmias with a cumulative incidence of 0.94% during a very long term follow-up of nearly 10 years from initially diagnosing sarcoidotic. Expand